STAT-A-MATRIX
provides the training, evaluation, planning, and consulting
your organization needs to comply with FDA’s CGMPs and PAT initiatives,
and to implement lean and Six Sigma tools.
The STAT-A-MATRIX (SAM) 14-step implementation process is easily adaptable
to companies seeking compliance with CGMPs for finished pharmaceuticals.
In addition, SAM can provide customized consulting services for FDA-regulated
organizations seeking assistance with design control, process validation,
risk assessment and analysis, PAT and Six Sigma tools, pharmaceutical
GMPs, good laboratory practices (GLPs), and responses to FDA findings.
Our seasoned industry experts, including former FDA investigators,
have worked with major medical device and international pharmaceutical
companies all over the world in such areas as:
FDA Compliance
Regulatory strategy development
Guidance on CGMP compliance for finished pharmaceuticals
Guidance on establishing and implementing the PAT initiatives
On-site audits
ISO 9001 Compliance
Crisis Intervention
FDA inspectional observations (Form 483)
Warning letters
Product recalls
International Compliance
ICH Q9 Quality Risk Management
ICH Q10 Draft Pharmaceutical Quality Management System